Trial Profile

A phase 3 study of RNS60 for Acute Ischemic Stroke

Status: Planning

Phase of Trial: Phase III

Latest Information Update: 28 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs RNS 60 (Primary)
Indications Ischaemic stroke
Focus Therapeutic Use
Acronyms RESTORE

Most Recent Events

14 Jul 2025 According to a Revalesio media release, The presentations will highlight the objectives and design of the company's upcoming Phase 3 clinical trial in acute ischemic stroke (AIS), RESTORE, presentations are scheduled for Thursday, July 17, 2025 from 12:20-12:25 p.m. CT. at the SNIS 22nd Annual Meeting.
11 Feb 2024 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com